Indole-based heterocyclic inhibitors of p38α MAP kinase: designing a conformationally restricted analogue
摘要:
p38alpha, Mitogen Activated Protein Kinase (MAP kinase) is an intracellular soluble serine threonine kinase. p38alpha kinase is activated in response to cellular stresses, growth factors and cytokines such as interleukin-1 (IL- 1) and tumor necrosis factor alpha (TNF-alpha). The central role of p38alpha activation in settings of both chronic and acute inflammation has led efforts to find inhibitors of this enzyme as possible therapies for diseases such as rheumatoid arthritis, where p38alpha activation is thought to play a causal role. Herein, we report structure-activity relationship studies on a series of indole-based heterocyclic inhibitors that led to the design and identification of a new class of p38alpha inhibitors. (C) 2003 Elsevier Ltd. All rights reserved.
Chloroform‐mediated acylative coupling of amines and indoles has been developed. Indoles and amines in chloroform were treated with dimethylzinc in the presence of air, resulting in a three‐component acylative coupling reaction in which in‐situ generation of phosgene produces indole‐3‐carboxamides.
AlMe<sub>3</sub>-Mediated Regio- and Chemoselective Reactions of Indole with Carbamoyl Electrophiles
作者:A. Velavan、S. Sumathi、K. K. Balasubramanian
DOI:10.1002/ejoc.201300085
日期:2013.5
we report the regio- and chemoselectivereactions of indole with carbamoylelectrophiles in presence of AlMe3. Indole-3-carboxamide was prepared in one-step from a reaction of indole with tertiary carbamoylimidazole in the presence AlMe3. Under conditions for the formation of an aluminium ate complex, the reaction was diverted to the indole nitrogen. Secondary carbamoylelectrophiles in the presence
(EN) Novel 3-Carboxyindole piperazine amide containing compounds, and compositions for use in therapy as anti-inflammatory agents, and inhibitors of cytokine p38/MAP kinase mediated diseases.(FR) On décrit des nouveaux composés amidés contenant 3-carboxyindole pipérazine, ainsi que des compositions utiles en thérapie en tant qu'agents anti-inflammatoires, et en tant qu'inhibiteurs des cytokines p38/MAP kinases, dans des maladies induites par celles-ci.